Justin J. Noznesky, SVP, Marketing & Business Develop at AtriCure, Inc. (ATRC), sold 4,000 shares at $17.03 ($68K) on 2018-02-15, disclosed to the SEC on 2018-02-16.
Open-market sale of $68k ATRC by SVP, Marketing & Business Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATRC | SELL | 2025-09-16 | $218K | — | Filing → |
| ATRC | SELL | 2024-05-03 | $36K | — | Filing → |
| ATRC | SELL | 2024-04-03 | $46K | — | Filing → |